USPTO serial 90843701
SEECURE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 23, 2022
- Examiner
- TAYLOR, SLOAN H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEECURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher M. Thomas
301 FAYETTEVILLE STREET, SUITE 1400RALEIGH, NC 27601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Labeled syringe caps to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of syringes filled with pharmaceutical preparations for the treatment and prevention of viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, psychiatric diseases and disorders, immune system diseases and disorders, cancer, joint disease, respiratory diseases and disorders, allergies, and asthma; labeled port caps to reduce user error and assist with the correct selection of medication and medical products, sold as an integral component of intravenous bags filled with pharmaceutical preparations for the treatment and prevention of viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, psychiatric diseases and disorders, immune system diseases and disorders, cancer, joint disease, respiratory diseases and disorders, allergies, and asthma | ACTIVE | Feb 21, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 23, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 29, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |